Coegin Pharma is listed on NGM Nordic SME
The company's share capital amounts to SEK 4,694,549.5 distributed over 9,389,099 shares, each with a quota value of SEK 0.5 per share. All shares have equal voting value and share in the capital.
Coegin Pharma AB
The company has 10,000,000 outstanding warrants of the 2020/2024 series, of which 3,000,000 have been assigned to keypersons in the company. Each ninetyfive (95) warrants entitles the holder to subscribe for one new share in the company during the period from October 1, 2024 to December 31, 2024 at a price of SEK 24 per share.
Full use of all warrants means a dilution effect of no more than 0.3 percent of the number of shares and votes in the company.
NGM Nordic SME
Nordic SME is a growth market for small and medium-sized enterprises for listing and trading of shares and share-based securities, operated by Nordic Growth Market NGM AB. Nordic SME is a growth market for small and medium-sized enterprises in accordance with MiFID II (Markets in Financial Instruments Directive II). Investors should take into consideration that shares and share-based securities admitted to trading on Nordic SME are not traded on a regulated market and that the company thus is not subject to the same regulations protecting shareholders as a company listed on a regulated market.